Previous 10 | Next 10 |
Gainers: [[JAX]] +4.5%. [[AXGT]] +4.4%. [[HRI]] +3.1%. [[AVDL]] +2.3%. [[AAL]] +1.7%.Losers: [[TATT]] -6.2%. [[FNKO]] -3.5%. [[IMGN]] -3.0%. [[VIVO]] -2.6%. [[INMD]] -1.6%. For further details see: AXGT, AVDL, INMD and IMGN among after-hours movers
Shares of InMode (NASDAQ: INMD) were surging 14.7% at 3:30 p.m. EDT on Monday after management unveiled plans allowing it to repurchase up to 1 million shares in the open market. The healthcare company 's medical devices are used to perform aesthetic treatments, including liposuction...
InMode ( INMD +10.7% ) trades higher after the health care equipment company announces its shareholder return program through 1M of shares buyback. More news on: InMode Ltd., Healthcare stocks news, , Stocks on the move, Read more ...
YOKNEAM, Israel , Sept. 2, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that its Board of Directors has approved a share repurchase program of up to 1 million ordinary shares on the open market or otherwi...
Quick Take InMode ( INMD ) went public in August, 2019, selling five million shares at $14.00 to collect $70 million in gross proceeds. The firm has been commercializing its adipose fat tissue remodeling technologies. INMD has managed its business through the Covid-19 pandemic for long...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...
LAKE FOREST, Calif. , Aug. 13, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce a new FDA clearance to market the Morpheus8 Body handpiece and Morpheus8 Platform. ...
Image source: The Motley Fool. InMode Ltd. (NASDAQ: INMD) Q2 2020 Earnings Call Aug 05, 2020 , 8:30 a.m. ET Operator Continue reading
InMode Ltd. (INMD) Q2 2020 Earnings Conference Call Aug 05, 2020, 08:30 AM ET Company Participants Miri Segal - MS, IR Moshe Mizrahy - CEO & Chairman Michael Kreindel - Co-Founder and CTO Shakil Lakhani - President of InMode, North America Yair Malca - CFO Spero Theodor...
InMode (NASDAQ: INMD ) : Q2 Non-GAAP EPS of $0.24 beats by $0.03 ; GAAP EPS of $0.21. More news on: InMode Ltd., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire Believes InMode's Cash Balance of Roughly 55% of its Market Cap is Grossly Inefficient Asserts the Current Valuation Offers an Unprecedented Oppo...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...